SBI Securities
IMMX icon

SBI Securities’s Immix Biopharma IMMX Stock Holding History

SBI Securities’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$104K Hold
10,000
– – ﹤0.01% 891
2026
Q2 		$103K Hold
10,000
– – ﹤0.01% 906
2026
Q1 		$91.1K Hold
10,000
– – ﹤0.01% 880
2025
Q4 		$52.3K Sell
10,000
-7,500
-43% -$30.9K ﹤0.01% 1067
2025
Q3 		$36.6K Hold
17,500
– – ﹤0.01% 1205
2025
Q2 		$36.2K Hold
17,500
– – ﹤0.01% 1177
2025
Q1 		$29.4K Hold
17,500
– – ﹤0.01% 1182
2024
Q4 		$38.5K Buy
+17,500
New +$32K ﹤0.01% 1062

Other funds holding IMMX

Certuity
Certuity North Palm Beach, Florida $2.13B AUM 70.4% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Prosperity Capital Advisors
Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 15.9% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Compass Financial Management
Compass Financial Management Tampa, Florida $926M AUM
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SBI Securities's IMMX Position: Q3 2026 in Review

SBI Securities held its Immix Biopharma (IMMX) position steady in Q3 2026 at 10,000 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

SBI Securities first reported a position in IMMX in Q4 2024 and has held it in 8 quarters since. 20 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • SBI Securities held 10,000 shares of Immix Biopharma worth $104K as of Q3 2026.
  • SBI Securities left its Immix Biopharma share count unchanged in Q3 2026.
  • Immix Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #891 holding.
  • SBI Securities first reported a position in Immix Biopharma in Q4 2024 and has held it in 8 quarters since.
  • 20 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.